Skip to main content

Table 5 Odds ratios (OR) and 95% confidence (CIs) intervals for case–control associations with BMI, education and annual income for early and advanced stage ovarian cancer, the African American Cancer Epidemiology Study (AACES), 2010-14†

From: A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES)

 

Early Stage at Diagnosis (Stage I/II)

Advanced Stage at Diagnosis (Stage III/IV)

Variable

Controls (N = 622)

Cases (N = 168)

    

Cases (N = 182)

    
 

N (%)

N (%)

OR*

(95% CI)

OR**

(95% CI)

N (%)

OR*

(95% CI)

OR**

(95% CI)

Body mass index 1 year before diagnosis (kg/m 2 )

           

<24.9

119 (19.2)

25 (14.9)

1.00

Referent

1.00

Referent

26 (14.4)

1.00

Referent

1.00

Referent

25–29.9

157 (25.3)

38 (22.6)

1.10

(0.63-1.93)

1.18

(0.66-2.08)

50 (27.6)

1.33

(0.77-2.27)

1.31

(0.76-2.26)

30–34.9

157 (25.3)

51 (30.4)

1.53

(0.90-2.62)

1.56

(0.90-2.68)

51 (28.2)

1.46

(0.85-2.49)

1.45

(0.84-2.48)

> = 35

188 (30.3)

54 (32.1)

1.33

(0.78-2.26)

1.33

(0.78-2.28)

54 (29.8)

1.31

(0.77-2.22)

1.23

(0.72-2.09)

Missing

1

     

1

    

Education

           

High school or less

223 (35.9)

80 (47.6)

1.00

Referent

1.00

Referent

84 (46.2)

1.00

Referent

1.00

Referent

Some post-high school training

227 (36.6)

47 (28.0)

0.60

(0.40-0.89)

0.59

(0.39-0.90)

62 (34.1)

0.78

(0.53-1.14)

0.84

(0.56-1.25)

College or graduate degree

171 (27.5)

41 (24.4)

0.69

(0.45-1.06)

0.65

(0.41-1.04)

36 (19.8)

0.59

(0.38-0.93)

0.67

(0.42-1.09)

Missing

1

          

Annual Income

           

< $10,000

130 (21.2)

43 (25.9)

1.00

Referent

1.00

Referent

37 (20.8)

1.00

Referent

1.00

Referent

$10,000 - < $25,000

145 (23.6)

41 (24.7)

0.85

(0.52-1.39)

0.86

(0.52-1.43)

49 (27.5)

1.15

(0.70-1.89)

1.19

(0.72-1.96)

$25,000 - < $50,000

131 (21.3)

41 (24.7)

0.96

(0.59-1.58)

0.96

(0.58-1.60)

43 (24.2)

1.17

(0.70-1.94)

1.27

(0.75-2.13)

$50,000 - < $75.000

103 (16.8)

23 (13.9)

0.68

(0.38-1.20)

0.69

(0.38-1.25)

23 (12.9)

0.79

(0.44-1.42)

0.91

(0.49-1.67)

≥ $75,000

105 (17.1)

18 (10.8)

0.52

(0.28-0.96)

0.54

(0.29-1.02)

26 (14.6)

0.90

(0.51-1.59)

1.09

(0.60-1.99)

Missing

8

2

    

4

    
  1. †Seventeen controls were excluded from this table; 14 cases excluded from the early stage cases and 17 cases excluded from advanced stage cases due to missing data for either parity or months of oral contraceptive use.
  2. *Age adjusted(ORs).
  3. **Multivariable adjusted (ORs) adjusted for age, months of oral contraceptive use, and parity.